Abstract 5308
Background
Carboplatin-Etoposide is a 1st-line (1L) option for patients (pts) with advanced EP-PD-NEC. Schedules with oral or IV ET are used in clinical practice. Data from randomised trials are lacking.
Methods
Records of pts diagnosed with advanced EP-PD-NEC and treated with CB/oral-ET and CB/IV-ET were reviewed retrospectively (09/96-02/17). First-line survival/activity/toxicity data are reported.
Results
One-hundred-thirteen pts were identified: median (med) follow-up was 11.5 months (m); med age was 65.8 years (range 24-88); male=64%; ECOG performance status 0-1=81%; no/mild comorbidities=81%; gastro-entero-pancreatic origin=54%; stage IV = 90% (53% liver metastases). Median Ki-67=70% (95%CI 60-80%), Ki-67>55%=59%. A total of 123 courses of CB-ET were administered: 106 (86%) 1L, 16 (13%) 2nd-line (2L) and 1 (1%) 3rd-line; med cycles/line=4; oral-ET 45%, IV-ET 55%. Median CB-ET dose-intensity (available for 82 courses): 96% (1L), 90% (2L). Median 1L-progression free survival (PFS) was 5.9m (95%CI 5.0-7.1): oral-ET 5.6m, IV-ET 6.2m, hazard ratio (HR)=0.76 (95%CI 0.51-1.14). Median 1L-overall survival (OS) was 11.5m (95%CI 8.9-13.6): oral-ET 8.9m, IV-ET 12.1m, HR = 0.68 (95%CI 0.45-1.03), p = 0.07. Radiological response (assessed for 95 pts), 1L-disease control rate was 75.8% (95%CI 67.1-84.6): oral-ET 69.8% (95%CI 55.5-84.1), IV-ET 80.8% (95%CI 69.7-91.8). Liver metastases were the only independent factor related to worse 1L-PFS on multivariable analysis, HR = 1.71 (95%CI 1.11-2.63). Commonest 1L-grade 3-4 adverse event (AE) was myelosuppression (47.2%); no significant differences between oral-ET and IV-ET AEs, except for venous thromboembolism; oral-ET 12.5%, IV-ET 1.7% (p = 0.04).
Conclusions
This is one of the largest series of pts with advanced EP-PD-NEC treated with CB-ET in the current literature. Oral-ET and IV-ET schedules are associated with comparable 1L-PFS/activity/toxicity data. There is a trend towards better 1L-OS for IV-ET schedules; this, however, may be driven by differences in patient selection between the two subgroups.
Clinical trial identification
Legal entity responsible for the study
The Christie NHS Foundation Trust.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract